Metraipolis › archive › dc_93ef2bce64f5
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial — Europe PMC PMID:40857084
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40857084
- DOI
- 10.1002/ejhf.3799
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T08:22:50.859Z
- SHA-256 of the archived text
4d1d7f845d32db53bc0eb55c30cbb0e359de510a5d2ce969f20f1b1ee8edabe5- Stable URL of this page
https://metraipolis.com/documento/dc_93ef2bce64f5
How to cite
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial — Europe PMC PMID:40857084 — Europe PMC (en), https://europepmc.org/article/MED/40857084 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93ef2bce64f5 (Metraipolis archive dc_93ef2bce64f5, sha256 4d1d7f845d32db53bc0eb55c30cbb0e359de510a5d2ce969f20f1b1ee8edabe5)
BibTeX
@misc{dc93ef2bce64f5,
title = {Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial — Europe PMC PMID:40857084},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40857084},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93ef2bce64f5; sha256 4d1d7f845d32db53bc0eb55c30cbb0e359de510a5d2ce969f20f1b1ee8edabe5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40857084. Agents can read the archived copy with the MCP tool read_document.